Scholarly Works - Preprints
Preprint
·
February 20, 2026
BACKGROUND AND AIMS: The glucagon-like peptide-1 receptor agonist (GLP-1 RA) semaglutide has demonstrated efficacy for the secondary prevention of cardiovascular disease among patients with overweight/obesity without diabetes mellitus. However, the compara ...
Full text
Link to item
Cite
Preprint
·
July 21, 2025
IMPORTANCE: A lack of transparent reporting of race and ethnicity in clinical research limits the ability to identify health inequities and evaluate to what extent clinical research includes diverse populations. OBJECTIVE: To identify study characteristics ...
Full text
Link to item
Cite
Preprint
·
December 21, 2023
BACKGROUND: Meta-analyses have suggested the risk of atherosclerotic cardiovascular disease (ASCVD) events is significantly higher after a chronic obstructive pulmonary disease (COPD) exacerbation. However, these studies have been limited to highly selecte ...
Full text
Link to item
Cite
